IPS cell sheets created by a novel magnetite tissue engineering method for reparative angiogenesis

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Kito, Tetsutaro ^a   Shibata, Rei ^a   Ishii, Masakazu ^a   Suzuki, Hirohiko ^a   Himeno, Tatsuhito ^a   Kataoka, Yoshiyuki ^a   Yamamura, Yumiko ^a   Yamamoto, Takashi ^a   Nishio, Naomi ^a   Ito, Sachiko ^a   Numaguchi, Yasushi ^a   Tanigawa, Tohru ^b   Yamashita, Jun K ^c   Ouchi, Noriyuki ^a   Honda, Hiroyuki ^d   Isobe, Kenichi ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LIPOSOME; MAGNETITE NANOPARTICLE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; EXTRACELLULAR MATRIX; HINDLIMB; ISCHEMIA; LASER DOPPLER FLOWMETRY; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PLURIPOTENT STEM CELL; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; INDUCED PLURIPOTENT STEM CELLS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LIPOSOMES; MAGNETITE NANOPARTICLES; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875124856     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01418     Document Type: Article

References (40)

1. Tateishi-Yuyama, E. et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427-435 (2002).
2. Higashi, Y. et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 109, 1215-1218 (2004). (Pubitemid 38372778)
3. Amann, B., Luedemann, C., Ratei, R. & Schmidt-Lucke, J. A. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 18, 371-380 (2009).
4. Idei, N. et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv 4, 15-25 (2011).
5. Assmus, B. et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355, 1222-1232 (2006). (Pubitemid 44427446)
6. Kajiguchi, M. et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 71, 196-201 (2007). (Pubitemid 46182692)
7. Matoba, S. et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. AmHeart J 156, 1010-1018 (2008).
8. Heeschen, C. et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109, 1615-1622 (2004). (Pubitemid 38451717)
9. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
10. Narazaki, G. et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498-506 (2008).
11. Taura, D. et al. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler Thromb Vasc Biol 29, 1100-1103 (2009).
12. Suzuki, H. et al. Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells. BMC Cell Biol 11, 72 (2010).
13. Zhang, M. et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33, 907-921 (2001). (Pubitemid 32545326)
14. Müller-Ehmsen, J. et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34, 107-116 (2002). (Pubitemid 35229976)
15. Pittenger, M. F. & Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9-20 (2004). (Pubitemid 38931831)
16. Tang, Y. L. et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46, 1339-1350 (2005). (Pubitemid 41615559)
17. Hattori, F. et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7, 61-66 (2010).
18. Ito, A. et al. Construction and harvest of multilayered keratinocyte sheets using magnetite nanoparticles and magnetic force. Tissue Eng 10, 873-880 (2004). (Pubitemid 38880406)
19. Shimizu, K. et al. Construction of multi-layered cardiomyocyte sheets using magnetite nanoparticles and magnetic force. Biotechnol Bioeng 96, 803-809 (2007). (Pubitemid 46395948)
20. Ito, A. et al. Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng 10, 833-840 (2004). (Pubitemid 38880402)
21. Ishii, M. et al. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler Thromb Vasc Biol 31, 2210-2215 (2011).
22. Suzuki, H. et al. Comparative angiogenic activities of induced pluripotent stem cells derived from young and old mice. PLoS One 7, e39562 (2012).
23. Hibino, N. et al. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg 143, 696-703 (2012).
24. Shimizu, T. et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature- responsive cell culture surfaces. Circ Res 90, e40 (2002).
25. Shimizu, T., Yamato, M., Kikuchi, A. & Okano, T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24, 2309-2316 (2003). (Pubitemid 36434050)
26. Miyagawa, S. et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 80, 1586-1595 (2005). (Pubitemid 43005870)
27. Memon, I. A. et al. Repair of impaired myocardium by means of implantation of engineered autologousmyoblast sheets. J Thorac Cardiovasc Surg 130, 1333-1341 (2005). (Pubitemid 41543202)
28. Shimizu, T. et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J 20, 708-710 (2006). (Pubitemid 46671189)
29. Matsuura, K. et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119, 2204-2217 (2009).
30. Miyahara, Y. et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12, 459-465 (2006).
31. Tse, H. F. et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 9, 747-753 (2007).
32. Tateno, K. et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 98, 1194-1202 (2006). (Pubitemid 43948106)
33. Kai, W., Xiaojun, X., Ximing, P., Zhenqing, H. & Qiqing, Z. Cytotoxic effects and the mechanism of three types of magnetic nanoparticles on human hepatoma BEL-7402 cells. Nanoscale research letters 6, 480 (2011).
34. Konczol, M. et al. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-kappaB. Chemical research in toxicology 24, 1460-1475 (2011).
35. Gao, L. et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nature nanotechnology 2, 577-583 (2007). (Pubitemid 47367542)
36. Ishii, M. et al. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler Thromb Vasc Biol 31, 2210-2215 (2011).
37. Okita, K., Nagata, N. & Yamanaka, S. Immunogenicity of induced pluripotent stem cells. Circ Res 109, 720-721 (2011).
38. Murohara, T. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101, 2567-2578 (1998). (Pubitemid 28270451)
39. Shibata, R. et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 279, 28670-28674 (2004). (Pubitemid 38900150)
40. Maruyama, S. et al. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism. J Biol Chem 286, 32790-32800 (2011).